Kidney health may change how this drug works in the body

NCT ID NCT04176536

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study investigates how moderate and severe kidney impairment affects the way the body processes a single dose of the drug BI 764198. Researchers compare people with kidney disease to healthy volunteers with normal kidney function. The goal is to understand how kidney function influences drug levels and safety, which could guide future dosing recommendations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BI 764198 (Apecotrep)
What this could lead to
If successful, this study could help determine safe dosing of BI 764198 for people with kidney problems.
What could go wrong
This is an early-phase study with a single dose, so results may not predict long-term effects or benefits. Kidney impairment may alter drug levels unpredictably.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CRS Clinical Research Services Kiel GmbH

    Kiel, 24105, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.